Effects of beta-cryptoxanthin on glucose metabolism (Acute phase)
Not Applicable
Recruiting
- Conditions
- IGT Type2 diabetes
- Registration Number
- JPRN-UMIN000012167
- Lead Sponsor
- Brain/Liver Interface Medicine Research Center, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.history of type 1 diabetes or history of ketoacidosis 2.history of hypoglycemia severe symptoms associated with loss of consciousness or coma 3.severe infection, the severe trauma 4. poorly controlled hypertension, systolic blood pressure >160 mmHg, or diastolic blood pressure >100 5.patients with grade 3 or more of the Ministry of Health, Labour and Welfare drug side effects classification serious complication 6.pregnancy or breast feeding 7.inability to participate in the study as assessed by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method